How to Help Your Patients Find Sucralfate in Stock: A Provider's Guide

When a patient calls your office or portal unable to fill their sucralfate prescription, the default response — "try a different pharmacy" — often isn't enough. With multiple pharmacy options and supply chains to navigate, patients can spend hours making calls before giving up. As a provider, you can streamline this process with a few targeted interventions that take minutes of your time but save your patients considerable frustration.

Understanding Why Patients Can't Find Sucralfate

Sucralfate availability gaps are primarily driven by intermittent back orders from specific manufacturers (ASHP has documented Teva's intermittent back orders due to demand increases) and uneven distribution across pharmacy wholesale networks. The result is that some pharmacies in a given area may be well-stocked while others are completely out — without any clear pattern a patient could identify on their own. The oral suspension is more prone to availability issues due to fewer competing generic manufacturers.

Importantly, sucralfate is not a controlled substance, which means transfers, early fills, and multi-pharmacy searches are not subject to DEA restrictions. This makes helping patients find it administratively simpler than for many other medications that face supply issues.

Step 1: Direct Patients to medfinder

The most efficient referral you can make is to medfinder.com. medfinder calls pharmacies on the patient's behalf to check which ones have the medication in stock near them. This eliminates the need for the patient to call 10 pharmacies on hold — and typically surfaces in-stock locations faster than a patient-led search.

You can include medfinder as a standard note in your discharge instructions or patient portal messages when prescribing sucralfate: "If you have trouble filling this prescription at your usual pharmacy, visit medfinder.com to locate which pharmacies near you have it in stock."

Step 2: Send the Prescription to Multiple Pharmacies

Since sucralfate is not a controlled substance, there is no restriction on sending an e-prescription to multiple pharmacies. Some EHR systems allow routing to a patient's preferred pharmacy; if that pharmacy doesn't fill it, you or your care team can send a new e-prescription to an alternate location identified by the patient. This avoids the fax/phone workflow that creates delays.

Step 3: Specify Generic with Manufacturer Flexibility

When prescribing, ensure your prescription allows generic substitution. Write "sucralfate 1g tablets" (or suspension) without restricting to a specific manufacturer. This gives the dispensing pharmacy flexibility to source from whichever manufacturer they have available — currently including Viatris, which has maintained supply during Teva's intermittent back orders.

Step 4: Address Formulation Flexibility When Clinically Appropriate

If you prescribed the oral suspension for a patient who can also take tablets (for example, a patient without dysphagia for whom you prescribed the suspension for preference reasons), consider noting in the prescription or a portal message that the tablet formulation is acceptable. Pharmacies cannot substitute formulations without prescriber authorization, but a quick portal message or secondary prescription can unlock this option.

Conversely, if a patient truly requires the suspension (swallowing difficulties, NG tube administration, specific mucosal applications), document this clearly so pharmacies do not attempt a tablet substitution.

Step 5: Empower Patients with a Calling Script

Patients who know exactly what to ask get results faster. Consider sharing this script in an after-visit summary or portal message:

"Hi, I need to fill a prescription for sucralfate 1g tablets (or suspension). Do you have it in stock right now? If not, can you order it from a different manufacturer? I'm looking specifically for the generic version, and I'm flexible on manufacturer."

Step 6: Pharmacist Collaboration

If your practice has a preferred or embedded pharmacist, ask them to identify which local pharmacies currently have sucralfate and update their list periodically. Hospital outpatient pharmacies and independently operated compounding pharmacies are often overlooked by patients but may have excellent access to sucralfate — particularly the suspension.

When to Bridge with an Alternative

For patients who cannot find sucralfate after a genuine search effort, a temporary bridge with a PPI or H2 blocker is often appropriate while the patient continues to look or waits for restocking. Key clinical considerations:

• Sucralfate interactions (levothyroxine, fluoroquinolones, digoxin) are eliminated when transitioning to a PPI/H2 blocker — adjust other medication timing accordingly.
• For patients on long-term sucralfate for maintenance therapy, transitioning to a PPI for a few weeks is generally low-risk, but monitor for PPI-associated side effects on longer courses.
• For ICU patients on sucralfate for VAP reduction, the clinical rationale for sucralfate is strongest — work with pharmacy and supply chain to source it if possible before switching.

Additional Resources for Providers

For a deeper clinical review of the supply situation and therapeutic alternatives, see our provider guide: Sucralfate Shortage: What Providers Need to Know in 2026. And to refer patients directly to a pharmacy search tool, point them to medfinder.com — a service that calls pharmacies on the patient's behalf to locate in-stock locations.